LUNG CANCER RISK FROM FORMALDEHYDE
- 17 April 1982
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 319 (8277), 913
- https://doi.org/10.1016/s0140-6736(82)92185-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- CAN THYROGLOBULIN ASSAY REALLY SUPPLANT RADIOIODINE SCANS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER?The Lancet, 1982
- Sequential Serum Thyroglobulin Determinations,131I Scans, and131I Uptakes After Triiodothyronine Withdrawal in Patients with Thyroid Cancer*Journal of Clinical Endocrinology & Metabolism, 1981
- The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancerAmerican Journal Of Medicine, 1981
- Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinomas: comparison of its value in patients with or without normal residual tissueActa Endocrinologica, 1981
- SERUM THYROGLOBULIN IN THYROID CANCERThe Lancet, 1981
- Serum thyroglobulin levels predict total body iodine scan findings in patients with treated well-differentiated thyroid carcinomaAmerican Journal Of Medicine, 1980
- CANCER RISK FROM FORMALDEHYDEThe Lancet, 1980
- Serum thyroglobulin in thyroid carcinoma and other thyroid disordersJournal of Endocrinological Investigation, 1980
- SERUM THYROGLOBULIN IN THE DIAGNOSIS AND MANAGEMENT OF THYROID CARCINOMAClinical Endocrinology, 1979
- Genetic and cytogenetical effects of formaldehyde and related compoundsMutation Research/Reviews in Genetic Toxicology, 1977